How to buy Align Technology shares | $507.08

Own Align Technology shares in just a few minutes. Share price changes are updated daily.

Fact checked

Align Technology, Inc (ALGN) is a leading medical devices business based in the US. It opened the day at $507 after a previous close of $508.39. During the day the price has varied from a low of $498.255 to a high of $509.5. The latest price was $507.08 (25 minute delay). Align Technology is listed on the NASDAQ and employs 14,530 staff. All prices are listed in US Dollars.

How to buy shares in Align Technology

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ALGN in this case.
  5. Research Align Technology shares. The platform should provide the latest information available.
  6. Buy your Align Technology shares. It's that simple.
The whole process can take as little as 15 minutes.

How has Coronavirus impacted Align Technology's share price?

Since the stock market crash in March caused by coronavirus, Align Technology's share price has had significant positive movement.

Its last market close was $326.84, which is 20.37% up on its pre-crash value of $260.26 and 155.58% up on the lowest point reached during the March crash when the shares fell as low as $127.88.

If you had bought $1,000 worth of Align Technology shares at the start of February 2020, those shares would have been worth $543.99 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,291.02.

Align Technology share price

Use our graph to track the performance of ALGN stocks over time.

Align Technology shares at a glance

Information last updated 2020-12-11.
Open$507
High$509.5
Low$498.255
Close$507.08
Previous close$508.39
Change $-1.31
Change % -0.258%
Volume 305,925
Information last updated 2020-12-27.
52-week range$127.88 - $543.654
50-day moving average $491.8897
200-day moving average $360.0567
Wall St. target price$472.21
PE ratio 24.0276
Dividend yield N/A (0%)
Earnings per share (TTM) $21.976
Promoted
eToro Free Stocks

Invest in Align Technology shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Your first 100 trades are free with Fineco, T&Cs apply.
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Stake
£0
£0
Zero platform fee
Join and receive a free share worth up to £100
Access unlimited commission-free trading on 3,800+ US stocks and ETFs with Stake. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Degiro Share Dealing
£1.75 + 0.022% (max £5.00)
£1.75 + 0.022% (max £5.00)
Portfolio transfer fees (in & out)
Degiro is widely seen as one of the best low-cost share brokers, for people who are looking to trade regularly. Capital at risk.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Open an ISA, Trading Account or SIPP you will get £100 of free trades to buy or sell any investment (new customers only).
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
0.61%
N/A
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
Penfold
Penfold
No minimum
4 portfolios
0.75-0.88%
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Align Technology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Align Technology price performance over time

Historical closes compared with the last close of $507.08

1 week (2021-01-08) -11.12%
1 month (2020-12-18) -4.31%
3 months (2020-10-16) 50.68%
6 months (2020-07-17) 57.33%
1 year (2020-01-17) 80.65%
2 years (2019-01-17) 138.44%
3 years (2018-01-17) 86.26%
5 years (2016-01-15) 747.11%

Is Align Technology under- or over-valued?

Valuing Align Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Align Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Align Technology's P/E ratio

Align Technology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Align Technology shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Align Technology's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

Align Technology's PEG ratio

Align Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.9394. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Align Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Align Technology's PEG ratio in relation to those of similar companies.

Align Technology's EBITDA

Align Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $421.6 million (£0.0 million).

The EBITDA is a measure of a Align Technology's overall financial performance and is widely used to measure a its profitability.

To put Align Technology's EBITDA into context you can compare it against that of similar companies.

Align Technology financials

Revenue TTM $2.3 billion
Operating margin TTM 14.22%
Gross profit TTM $1.7 billion
Return on assets TTM 6.01%
Return on equity TTM 80.12%
Profit margin 76%
Book value $38.472
Market capitalisation $41.6 billion

TTM: trailing 12 months

How to short and sell Align Technology shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "ALGN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.4 million Align Technology shares held short by investors – that's known as Align Technology's "short interest". This figure is 13.6% down from 1.7 million last month.

There are a few different ways that this level of interest in shorting Align Technology shares can be evaluated.

Align Technology's "short interest ratio" (SIR)

Align Technology's "short interest ratio" (SIR) is the quantity of Align Technology shares currently shorted divided by the average quantity of Align Technology shares traded daily (recently around 550456.48854962). Align Technology's SIR currently stands at 2.62. In other words for every 100,000 Align Technology shares traded daily on the market, roughly 2620 shares are currently held short.

To gain some more context, you can compare Align Technology's short interest ratio against those of similar companies.

However Align Technology's short interest can also be evaluated against the total number of Align Technology shares, or, against the total number of tradable Align Technology shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Align Technology's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Align Technology shares in existence, roughly 20 shares are currently held short) or 0.0206% of the tradable shares (for every 100,000 tradable Align Technology shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Align Technology.

Find out more about how you can short Align Technology stock.

Align Technology share dividends

We're not expecting Align Technology to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

You may also wish to consider:

Align Technology share price volatility

Over the last 12 months, Align Technology's shares have ranged in value from as little as $127.88 up to $543.654. A popular way to gauge a stock's volatility is its "beta".

ALGN.US volatility(beta: 1.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Align Technology's is 1.6751. This would suggest that Align Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Align Technology's beta into context you can compare it against those of similar companies.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Align Technology overview

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.

Frequently asked questions

More guides on Finder

  • How to buy Transportation and Logistics Systems shares

    Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Charlie’s Holdings shares

    Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Lemonade shares | $50.05

    Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Unity Software shares | $111.51

    Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor

  • How to buy FuelCell Energy shares | $3.745

    Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.

  • How to buy CloudCommerce shares | $0.1275

    Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor

  • How to buy Zomedica Pharmaceuticals shares | $0.93

    Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.

  • How to buy YRC Worldwide shares | $4.66

    Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.

  • How to buy Xeros Technology Group shares | 220p

    Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.

  • How to buy Xpediator shares | 33.5p

    Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site